Drugs / diphtheria/tetanus/acellular pertussis vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01028326 Background | Jan → Sep 2010 | streptococcal pneumonia | KEMRI-Wellcome Trust Collaborative Research Program | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | diphtheria/tetanus/acellular pertussis vaccine | “diphtheria/tetanus/acellular pertussis vaccine (DTaP)” PMID 24465570 ↗ Jan 2014 |
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01028326 ↗ |
| Modality | Vaccine | “diphtheria/tetanus/acellular pertussis vaccine (DTaP)” PMID 24465570 ↗ Jan 2014 |
| Route | Intramuscular | “0.5 mL intramuscular dose of DTaP on day 180” NCT01028326 ↗ |